EcoDrugPlus

Coagulation Factor Iiia

Ensembl ID : ENSCHAG00000011884
Gene Symbol: F3A
1 Cross references
199 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSCHAG00000003660
Gene Symbol: F7L
1 Cross references
203 Possible Orthologues:

Coagulation Factor X-Like

Ensembl ID : ENSCHAG00000003755
Gene Symbol: LOC105896532
3 Cross references
246 Possible Orthologues:

Coiled-Coil Domain Containing 6a

Ensembl ID : ENSCHAG00000022856
Gene Symbol: CCDC6A
1 Cross references
208 Possible Orthologues:

Coiled-Coil Domain Containing 6b

Ensembl ID : ENSCHAG00000011842
Gene Symbol: CCDC6B
1 Cross references
151 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSCHAG00000008400
Gene Symbol: CSF1R
1 Cross references
201 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, A

Ensembl ID : ENSCHAG00000021739
Gene Symbol: CSF1RA
1 Cross references
207 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSCHAG00000018050
Gene Symbol: CFD
3 Cross references
134 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSCHAG00000018889
Gene Symbol: CRHR1
3 Cross references
203 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSCHAG00000000288
Gene Symbol: CRHR1
1 Cross references
183 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSCHAG00000002200
Gene Symbol: CCND1
3 Cross references
205 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSCHAG00000024822
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).